Skip to main content
Erschienen in: Osteoporosis International 10/2007

01.10.2007 | Original Article

Cardiovascular diseases and future risk of hip fracture in women

verfasst von: U. Sennerby, B. Farahmand, A. Ahlbom, S. Ljunghall, K. Michaëlsson

Erschienen in: Osteoporosis International | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Summary

We used a population-based case-control study in women and linkage to the Swedish in-patient register to examine if there is an increased risk of hip fracture after a cardiovascular disease. There was a substantially increased risk of hip fracture after a diagnosis of a cardiovascular disease.

Introduction

Recent data have indicated that cardiovascular diseases (CVDs) might have a relationship to osteoporosis, which may explain the increased risk of mortality after hip fracture. It is uncertain, however, whether there is an increased risk of fracture after any cardiovascular disease and in subgroups of CVDs. The objective of this study was to determine whether there are associations between CVD and future hip fracture risk. Knowledge of the risk pattern would lead to better understanding of common pathologic pathways of osteoporosis and CVD.

Methods

We conducted a population-based case-control study of 1,327 incident hip fracture cases and 3,170 randomly selected population controls among women 50–81 years old in Sweden. Information on cardiovascular and other diseases before the fracture was obtained by linkage to the Swedish National Inpatient Register. Odds ratios (OR) and 95% confidence intervals (CI) where calculated by unconditional logistic regression.

Results

Before study entry, CVDs were diagnosed more than twice as commonly among fracture cases (25%) as among controls (12%). Also, after adjustment for variables including several chronic diseases, we found a doubled risk of hip fracture after a CVD event (OR 2.38; 95% CI 1.92–2.94). There was a gradient increase in risk of hip fracture with increasing number of hospitalizations for CVD and highest fracture risk occurred the first year after the CVD event. Hypertension, heart failure, and cerebrovascular lesions remained independent risk factors, with 2- to 3-fold increases in odds ratios, even after mutual adjustments for other CVDs.

Conclusion

There was a substantially increased risk of hip fracture in women after a diagnosis of a CVD, a finding compatible with the concept of common pathologic pathways for osteoporotic fractures and CVD.
Literatur
1.
Zurück zum Zitat Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in and women: an observational study. Lancet 353:878–882PubMedCrossRef Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in and women: an observational study. Lancet 353:878–882PubMedCrossRef
2.
Zurück zum Zitat Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Mortality after osteoporotic fractures. Osteoporosis Int 15:38–42CrossRef Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Mortality after osteoporotic fractures. Osteoporosis Int 15:38–42CrossRef
3.
Zurück zum Zitat Farahmand BY, Michaelsson K, Ahlbom A, Ljunghall S, Baron JA (2005) Survival after hip fracture. Osteoporosis Int 16:1583–1590CrossRef Farahmand BY, Michaelsson K, Ahlbom A, Ljunghall S, Baron JA (2005) Survival after hip fracture. Osteoporosis Int 16:1583–1590CrossRef
4.
Zurück zum Zitat Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporosis Int 15:389–395CrossRef Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporosis Int 15:389–395CrossRef
5.
Zurück zum Zitat Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification of 25-year period: The Framingham Heart Study. Calcif Tissue Int 68:271–276PubMedCrossRef Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification of 25-year period: The Framingham Heart Study. Calcif Tissue Int 68:271–276PubMedCrossRef
6.
Zurück zum Zitat von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278PubMedCrossRef von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278PubMedCrossRef
7.
Zurück zum Zitat Marcovitz PA, Tran HH, Franklin BA, O’Neill WW, Yerkey M, Boura J, Kleerkoper M, Dickinson CZ (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96:1059–1063PubMedCrossRef Marcovitz PA, Tran HH, Franklin BA, O’Neill WW, Yerkey M, Boura J, Kleerkoper M, Dickinson CZ (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96:1059–1063PubMedCrossRef
8.
Zurück zum Zitat Collin-Osdoby P (2004) Regulation of vascular calcification by osteoclast regulatory factors RANK-L and osteoprotegerin. Circ Res 95:1046–1057PubMedCrossRef Collin-Osdoby P (2004) Regulation of vascular calcification by osteoclast regulatory factors RANK-L and osteoprotegerin. Circ Res 95:1046–1057PubMedCrossRef
9.
Zurück zum Zitat Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANK-L regulated osteoclast differentiation. J Clin Inv 114(4):475–484CrossRef Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANK-L regulated osteoclast differentiation. J Clin Inv 114(4):475–484CrossRef
10.
Zurück zum Zitat Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocr Rev 13:66–80PubMedCrossRef Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocr Rev 13:66–80PubMedCrossRef
11.
Zurück zum Zitat Kwan Tat S, Padrines M, Theoleyre S, Heyman D, Fortun Y (2004) IL-6, RANK TNF-alpha/IL-1: interrelation in bone resorption. Cytokine Growth Factor Rev 15:49–60PubMedCrossRef Kwan Tat S, Padrines M, Theoleyre S, Heyman D, Fortun Y (2004) IL-6, RANK TNF-alpha/IL-1: interrelation in bone resorption. Cytokine Growth Factor Rev 15:49–60PubMedCrossRef
12.
Zurück zum Zitat Theill LE, Boyle WJ, Penninger JM (2002) RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol 20:795–823PubMedCrossRef Theill LE, Boyle WJ, Penninger JM (2002) RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol 20:795–823PubMedCrossRef
13.
Zurück zum Zitat Cappucio FP, Meilahn E, Zmuda JM, Cauley JA (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 18:354(9183):971–975CrossRef Cappucio FP, Meilahn E, Zmuda JM, Cauley JA (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 18:354(9183):971–975CrossRef
14.
Zurück zum Zitat Johnell O, Kanis JA, Oden A, Johansson H, DeLaet C, Delmas P, Eisman JA, Fujuwara S, Kroger H, Mellström D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194PubMedCrossRef Johnell O, Kanis JA, Oden A, Johansson H, DeLaet C, Delmas P, Eisman JA, Fujuwara S, Kroger H, Mellström D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194PubMedCrossRef
15.
Zurück zum Zitat Mussolino ME, Madans JH, Gillum RF (2003) Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol 13(10):692–697, NovPubMedCrossRef Mussolino ME, Madans JH, Gillum RF (2003) Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol 13(10):692–697, NovPubMedCrossRef
16.
Zurück zum Zitat Michaelsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S (1999) Oral-contraceptive use and risk of hip fracture:a case control study. Lancet 1;353(9163):1481–1484CrossRef Michaelsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S (1999) Oral-contraceptive use and risk of hip fracture:a case control study. Lancet 1;353(9163):1481–1484CrossRef
17.
Zurück zum Zitat Michaelsson K, Baron J, Farahmand BY, Johnell O, Magnusson C, Persson PG, Persson I, Ljunghall S (1998) Hormone replacement therapy and risk of hip fracture: population based case-control study. The Hip Fracture Study Group. BMJ 20;316(7148):1858–1863 Michaelsson K, Baron J, Farahmand BY, Johnell O, Magnusson C, Persson PG, Persson I, Ljunghall S (1998) Hormone replacement therapy and risk of hip fracture: population based case-control study. The Hip Fracture Study Group. BMJ 20;316(7148):1858–1863
18.
Zurück zum Zitat Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C; Prospective Epidemiological Risk Factors Study Group (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259:598–605PubMedCrossRef Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C; Prospective Epidemiological Risk Factors Study Group (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259:598–605PubMedCrossRef
19.
Zurück zum Zitat Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246–4253PubMedCrossRef Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246–4253PubMedCrossRef
20.
Zurück zum Zitat Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912–1920PubMedCrossRef Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912–1920PubMedCrossRef
21.
Zurück zum Zitat Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Review; Osteoporosis and cardiovascular disease. Brittle Bones and Boned Arteries. Is there a link? Endocrine 23(1):1–10CrossRef Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Review; Osteoporosis and cardiovascular disease. Brittle Bones and Boned Arteries. Is there a link? Endocrine 23(1):1–10CrossRef
22.
Zurück zum Zitat Bevilacqua M, Dominguez LJ, Rosini S, Bargallo M (2005) Bisphonates and atherosclerosis: why? Lupus 14(9):773–779PubMedCrossRef Bevilacqua M, Dominguez LJ, Rosini S, Bargallo M (2005) Bisphonates and atherosclerosis: why? Lupus 14(9):773–779PubMedCrossRef
23.
Zurück zum Zitat Power ML, Heaney RP, Kalkwarf HJ, Pitkin RM, Repke JT, Tsang RC, Schulkin J (1999) The role of calcium in health and disease. Am J Obstret Gynecol 181(6):1560–1569CrossRef Power ML, Heaney RP, Kalkwarf HJ, Pitkin RM, Repke JT, Tsang RC, Schulkin J (1999) The role of calcium in health and disease. Am J Obstret Gynecol 181(6):1560–1569CrossRef
24.
Zurück zum Zitat Zitterman A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Am J Obstet Gynecol 94(4):483–492 Zitterman A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Am J Obstet Gynecol 94(4):483–492
25.
Zurück zum Zitat Fujita T (1985) Aging and calcium as an environmental factor. J Nutr Sci Vitaminol Suppl:S15–S19 Fujita T (1985) Aging and calcium as an environmental factor. J Nutr Sci Vitaminol Suppl:S15–S19
26.
Zurück zum Zitat Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link. Endocrine 23(1):1–10CrossRef Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link. Endocrine 23(1):1–10CrossRef
27.
Zurück zum Zitat Baldini V, Mastropasqua M, Francucci CM, D’Erasmo E (2005) Cardiovascular disease and osteoporosis. J Endocrinol Invest 28(10 Suppl):69–72PubMed Baldini V, Mastropasqua M, Francucci CM, D’Erasmo E (2005) Cardiovascular disease and osteoporosis. J Endocrinol Invest 28(10 Suppl):69–72PubMed
28.
Zurück zum Zitat Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631–637PubMedCrossRef Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631–637PubMedCrossRef
29.
Zurück zum Zitat Tsutsui T, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Ohnishi M, Kinoshita M (2002) Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic heart failure. J Am Coll Cardiol 20;39(6):957–962CrossRef Tsutsui T, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Ohnishi M, Kinoshita M (2002) Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic heart failure. J Am Coll Cardiol 20;39(6):957–962CrossRef
30.
Zurück zum Zitat Frostegard J, Wu R, Lemne C, Thulin T, Witzum JL, de Faire U (2003) Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci (Lond) 105(5):815–820 Frostegard J, Wu R, Lemne C, Thulin T, Witzum JL, de Faire U (2003) Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci (Lond) 105(5):815–820
31.
Zurück zum Zitat Koh JM, Young-Sun L, Yang Son K, Duk Jae K, Hong-Hee K, Joong-Yeol P, Ki-Up L, Ghi Su K (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21(7):1003–1011PubMedCrossRef Koh JM, Young-Sun L, Yang Son K, Duk Jae K, Hong-Hee K, Joong-Yeol P, Ki-Up L, Ghi Su K (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21(7):1003–1011PubMedCrossRef
32.
Zurück zum Zitat McLean RR, Jacues PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 13;350(20):2042–2049CrossRef McLean RR, Jacues PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 13;350(20):2042–2049CrossRef
33.
Zurück zum Zitat van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 13;350(20):2033–2041CrossRef van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 13;350(20):2033–2041CrossRef
34.
Zurück zum Zitat Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2;293(9):1082–1088CrossRef Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2;293(9):1082–1088CrossRef
35.
Zurück zum Zitat Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D’Agostini RB (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction; Framingham Heart Study. Circulation 107:1486–1491PubMedCrossRef Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D’Agostini RB (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction; Framingham Heart Study. Circulation 107:1486–1491PubMedCrossRef
36.
Zurück zum Zitat Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G (2003) Homocysteine and essential hypertension. J Clin Pharmacol 43(12):1299–1306PubMedCrossRef Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G (2003) Homocysteine and essential hypertension. J Clin Pharmacol 43(12):1299–1306PubMedCrossRef
37.
Zurück zum Zitat Douchi T, Yamamoto S, Oki T et al (2000) Difference in the effect of adiposity on bone density between pre- and postmenopausal women. Maturitas 34:261–266PubMedCrossRef Douchi T, Yamamoto S, Oki T et al (2000) Difference in the effect of adiposity on bone density between pre- and postmenopausal women. Maturitas 34:261–266PubMedCrossRef
38.
Zurück zum Zitat Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546–551PubMedCrossRef Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546–551PubMedCrossRef
39.
Zurück zum Zitat Lechnik L, Register TC, Hsu FC et al (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646–651CrossRef Lechnik L, Register TC, Hsu FC et al (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646–651CrossRef
40.
Zurück zum Zitat Rajala MW, Scherer PE (2003) Mini-review: the adipocyte-at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765–3773PubMedCrossRef Rajala MW, Scherer PE (2003) Mini-review: the adipocyte-at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765–3773PubMedCrossRef
41.
Zurück zum Zitat Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556PubMedCrossRef Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556PubMedCrossRef
42.
Zurück zum Zitat Melton LJ 3rd, Brown RD Jr, Achenbach SJ, O’Fallon WM, Whisnant JP (2001) Long-Term fracture risk following ischemic stroke: a population-based study. Osteoporos Int 12:980–986PubMedCrossRef Melton LJ 3rd, Brown RD Jr, Achenbach SJ, O’Fallon WM, Whisnant JP (2001) Long-Term fracture risk following ischemic stroke: a population-based study. Osteoporos Int 12:980–986PubMedCrossRef
43.
Zurück zum Zitat Lindblad U, Ranstam L, Ranstam J, Peterson M (1993) Validity of register data on myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 21:3–9PubMed Lindblad U, Ranstam L, Ranstam J, Peterson M (1993) Validity of register data on myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 21:3–9PubMed
44.
Zurück zum Zitat Ingelsson E, Ärnlöv J, Sundström J, Lind L (2005) The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7:787–791PubMedCrossRef Ingelsson E, Ärnlöv J, Sundström J, Lind L (2005) The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7:787–791PubMedCrossRef
Metadaten
Titel
Cardiovascular diseases and future risk of hip fracture in women
verfasst von
U. Sennerby
B. Farahmand
A. Ahlbom
S. Ljunghall
K. Michaëlsson
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 10/2007
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-007-0386-0

Weitere Artikel der Ausgabe 10/2007

Osteoporosis International 10/2007 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.